Listen on NewsRamp PodcastsFollow us on Google News

Get your free copy of the News Marketing Bookhere

Blockchain Transaction Record


Leonhardt Ventures LLC and Licensee Lionheart Health, Inc. Granted U.S. Patent for Bioelectric Stem Cell Homing, Proliferation & Differentiation

Leonhardt Ventures LLC is pleased to announce the issuance of U.S. Leonhardt et. al. Patent 12,109,410 with 15 claims entitled “Bioelectric Stimulator”, a significant advancement in the field of regenerative medicine.

Exclusively at Newsworthy.ai — Newsworthy registers every press release distributed through this service on the blockchain so that we can provide verification services and make features such as the self-hosting of press releases available to our customers. The blockchain provides an immutable record of the press releases issued by this service. Immutability gives readers the assurance that the news they are reading has not been altered from the source document that this service distributed. We have shifted the Source of Truth to the blockchain for added protection.

Moving the Source of Truth to the blockchain improves transparency and increases trust between organizations submitting news and readers.

Key Takeaways (TLDR)

  • Leonhardt Ventures unveils patented bioelectric stimulator for regenerative medicine and organ regeneration advancements.
  • Lionheart Health applies pioneering technology for skin, hair, joint health, and healthspan improvement.
  • Various Leonhardt Ventures spin-offs utilize bioelectric stimulation for heart, brain, and major organ regeneration.
BlockchainDetails
Chainpolygon-main
Transaction ID0xbd9fed21fc8a26420e426ce25dcb586fcdc08105993540aba98f0312da6e99d5
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
NWAI Digital Fingerprint1394-01780d722c622b42ea3be01ad8596c80
Registration Timestamp2024-12-20T19:45:15+00:00

Other Recent Blockchain Registered News for Lionheart Health Inc.